We would love to hear your thoughts about our site and services, please take our survey here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Having read through the RNS I can say it is impossible to understand or speculate what this means in terms of SP. 4D have taken advice at significant cost and if this is the most cost effective entry to Nasdaq and part of their journey to successful development of the company then so be it. Getting funding and realising the potential may also be speeded up so shareholders may be more rewarded more quickly.
I wonder if the shorter is attacking again to hold the price down, this RNS all seems positive imho. I guess just have to see where the day takes us.
On reading this all sounds good to me, those worried re changing to nas, 4d shares wont and will remain as is
Also states that mrx018 collaboration with Merck and if anyone saw it also pfizer. Looks like a good year ahead to me
Imo only of course
The 40% will be issued in ADSs / traded on Nasdaq. This is a huge step for the company. I foresee our AIM listed shares continue to grow in value as the US market sees the potential of 4D and as those Nasdaq shares multiply in value quickly, so ours will follow.
Not negative just realistic. Just think any value created by NASDAQ will be offset by the increase in the number of shares less the cash they get for them obviously. And no, I’m in already and don’t want any more - I’m already at two bags
“If 40% of the company is in the hands of sector specialist II’s, that’s fine with me.”
My post was ambiguous. If up to 40% of additional shares are issued to II’s, I am very comfortable with this.
There will be those who always see the negatives and then those who can see the bigger picture. Given the general market lethargy at present, I suspect there will be opportunities to add further pre-merger.
Institutional investors only . That's how much interest.
Boom
Thanks Trek, nice to see some positive input.
I’m no longer a holder but have watched with interest. DDDD has always been a high cash burn venture. I think the BoD have done a great job with this deal. DP is a top exec, it never ceases to amaze me how he manages to innovate funding. The forced warrant conversions and the Longevity cash will ‘hopefully’ see one project over the line, and it will only take one. Blautix is the one that could be a massive company maker. Keep an eye on the cash, but I would expect another deal after listing. My money would be on Merck investing more once US listed.
I hope it comes good for investors and pt’s alike. Made my money here but still wish all well.
Good luck
Trek
If 40% of the company is in the hands of sector specialist II’s, that’s fine with me.
Any fundraising should come as zero surprise, it’s been in many previous RNS announcements that the merger would provide working capital to Q3.
Personally, I will be taking advantage of any dips to top up.
It's only dilution if they are given away which they wont be. The discount represents some dilution if occurs. But point of a merger is to add value.
Stupid to talk in such negative terms ahead of open unless trying to get in lower.
The Board is therefore seeking approval at the General Meeting to issue new shares on a non-pre-emptive basis for up to 40 per cent. of the Company's Enlarged Issued Share Capital (following Completion). The Board will update Shareholders as appropriate regarding any future funding proposals. It remains of the opinion that the NASDAQ Listing will provide access to specialist healthcare investors in the US.
Sorry. Issuance of up to 40% new shares
OldTownHat
How do you get to 40% dilution ? I think we are missing information to work that out ie the strike price of warrants. I'm happy to be corrected
I definitely regret not topping up at 132 the other day now! Thought I had another week for a low point.
Wow! A lot to take in but up to 40% dilution probably by Q3. Probably will keep the price where it is now as it’s 50% undervalue. 2022 is going to be an epic year. So much detail and nothing really to get upset about
Fabtastic :-)
Wha is not to like about DDDD good times ahead
22nd March guys and gals!
https://twitter.com/4dpharmaplc/status/1365197309076774915?s=20
Hold onto your hats, it’s going to be an epic ride!
https://www.londonstockexchange.com/news-article/DDDD/posting-of-circular/14879747
General Meeting called by 4D to approve merger.
It’s really happening!